{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T16:36:37Z","timestamp":1773678997704,"version":"3.50.1"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,24]],"date-time":"2023-07-24T00:00:00Z","timestamp":1690156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,24]],"date-time":"2023-07-24T00:00:00Z","timestamp":1690156800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Zoetis LLC"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Vet Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Corticosteroids are widely used with low rates of reported side effects and a broad level of comfort in the hands of most veterinarians. With a low side effect reporting level of\u2009&lt;\u20095% and high level of comfort there may be complacency and underestimation of the impact side effects of corticosteroids may have on a pet and pet owner.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>The objective of this clinical study was to describe the experience and perception of an owner who administered anti-inflammatory doses of oral prednisolone and prednisone to their dog for up to 14\u00a0days. We hypothesized dogs receiving anti-inflammatory doses of prednisone and prednisolone would experience much greater rates of side effects by day 14 then reported in current literature.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Animals<\/jats:title>\n                    <jats:p>There were 45 dogs initially enrolled in the study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>At each study point, 31 owners provided results. On day 5, 74% (23\/31) reported at least 1 change in their dog\u2019s behavior including polyuria, polydipsia, polyphagia, polypnea and\/or increased vocalization, with 11 individuals (35%) reporting these changes greatly increased. On day 14, 90% of owners (28\/31) reported at least 1 change in their dog\u2019s behavior including polyuria, polydipsia, polyphagia, and\/or polypnea as the most common changes noted. Overall, 61% (19\/31) of owners reported an increase in filling of the water bowl over baseline and one-third (11\/31) of pet owners reported cleaning up urinary accidents for pets who had been continent prior to the start of the study. Pet owner steroid satisfaction remained high through day 14 at 4.5\/5 (1\u2009=\u2009very unsatisfied, 5\u2009=\u2009very satisfied).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study highlights the impact short term anti-inflammatory doses of prednisone or prednisolone have on dog behaviour and confirms our hypothesis that by day 14, 90% of dogs experienced one or more behaviour changes, with polyuria and polydipsia most commonly reported. Adverse events were noted regardless of starting dosage or regimen. Although most pet owners expressed satisfaction with steroid treatment due to its high efficacy, 70% would select a more costly treatment if that treatment had fewer side effects.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12917-023-03644-x","type":"journal-article","created":{"date-parts":[[2023,7,24]],"date-time":"2023-07-24T06:02:17Z","timestamp":1690178537000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Perception and usage of short-term prednisone and prednisolone in dogs"],"prefix":"10.1186","volume":"19","author":[{"given":"Margaret","family":"Gober","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Hillier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,7,24]]},"reference":[{"key":"3644_CR1","unstructured":"Boothe D., and Mealey K. Glucocorticoids and Mineralocorticoids. In: Small Animal Clinical Pharmacology and Therapeutics. St. Louis; 2012. 1119\u20131149."},{"key":"3644_CR2","first-page":"400","volume-title":"Kirk's current veterinary therapy: XIV","author":"C Sousa","year":"2009","unstructured":"Sousa C. Glucocorticoids in Veterinary Dermatology. In: Kirk\u2019s current veterinary therapy: XIV. St. Louis: Elsevier Saunders; 2009. p. 400\u20135."},{"key":"3644_CR3","volume-title":"Merck Veterinary Manual.","author":"S Edwards","year":"2022","unstructured":"Edwards S. Corticosteroids in Animals. In: Merck Veterinary Manual. 2022. https:\/\/www.merckvetmanual.com\/pharmacology\/inflammation\/corticosteroids-in-animals Accessed 7 Jan 2022 ."},{"issue":"3\u20134","key":"3644_CR4","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S0165-2427(01)00296-3","volume":"81","author":"A Hillier","year":"2001","unstructured":"Hillier A, Griffin C. The ACVD task force on canine atopic dermatitis (I): incidence and prevalence. Vet Immunol Immunopathol. 2001;81(3\u20134):147\u201351.","journal-title":"Vet Immunol Immunopathol"},{"key":"3644_CR5","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.physbeh.2015.08.041","volume":"151","author":"L Notari","year":"2015","unstructured":"Notari L, Burman O, Mills D. Behavioral changes in dogs treated with corticosteroids. Physiol Behav. 2015;151:609\u201316.","journal-title":"Physiol Behav"},{"key":"3644_CR6","doi-asserted-by":"publisher","first-page":"515","DOI":"10.3389\/fvets.2020.00515","volume":"7","author":"DA Elkholly","year":"2020","unstructured":"Elkholly DA, et al. Side Effects to Systemic Glucocorticoid Therapy in Dogs Under Primary Veterinary Care in the UK. Front Vet Sci. 2020;7:515.","journal-title":"Front Vet Sci"},{"issue":"9596","key":"3644_CR7","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","volume":"370","author":"E Von Elm","year":"2007","unstructured":"Von Elm E, Altman DG, Egger M, et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453\u20137.","journal-title":"Lancet"},{"issue":"2","key":"3644_CR8","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S0195-5616(97)50027-1","volume":"27","author":"E Behrend","year":"1997","unstructured":"Behrend E, Kemppainen R. Glucocorticoid Therapy; Pharmacology, Indications and Complications. Vet Clin N Am. 1997;27(2):187\u2013213.","journal-title":"Vet Clin N Am"},{"issue":"3\u20134","key":"3644_CR9","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/S0165-2427(01)00314-2","volume":"81","author":"T Olivry","year":"2001","unstructured":"Olivry T, Sousa C. ACVD task force on canine atopic dermatitis: glucocorticoid pharmacotherapy. Veterinary Immunology. 2001;81(3\u20134):317\u201322.","journal-title":"Veterinary Immunology"},{"issue":"3","key":"3644_CR10","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/j.1365-3164.2010.00889.x","volume":"21","author":"T Olivry","year":"2010","unstructured":"Olivry T, et al. Treatment of canine atopic dermatitis: 2010 clinical practice guidelines from the International Task Force on Canine Atopic Dermatitis. Vet Dermatol. 2010;21(3):233\u201348.","journal-title":"Vet Dermatol"},{"key":"3644_CR11","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s12917-015-0514-6","volume":"11","author":"T Olivry","year":"2015","unstructured":"Olivry T, et al. Treatment of canine atopic dermatitis: 2015 updated guidelines from the International Committee on Allergic Diseases of Animals (ICADA). BMC Vet Res. 2015;11:210.","journal-title":"BMC Vet Res."}],"container-title":["BMC Veterinary Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-023-03644-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12917-023-03644-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-023-03644-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,24]],"date-time":"2023-07-24T06:04:11Z","timestamp":1690178651000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcvetres.biomedcentral.com\/articles\/10.1186\/s12917-023-03644-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,24]]},"references-count":11,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3644"],"URL":"https:\/\/doi.org\/10.1186\/s12917-023-03644-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2136446\/v1","asserted-by":"object"}]},"ISSN":["1746-6148"],"issn-type":[{"value":"1746-6148","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,24]]},"assertion":[{"value":"5 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All study participants were informed of the purpose of this study and written informed consent was obtained. Data from all pets and pet owners was anonymized and all legal requirements to protect this data have been adhered to<b>.<\/b> This study was reviewed and approved by the Zoetis Ethics Review Board.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"91"}}